{"id":"W2593722738","doi":"10.1016/s1470-2045(17)30168-7","title":"Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Regional Municipality of Durham; Hamilton Health Sciences; Juravinski Cancer Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Prednisone; Clusterin; Internal medicine; Clinical endpoint; Oncology; Population; Enzalutamide; Randomized controlled trial; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008096152,0.0002042734,0.0009488841,0.00006573337,0.0002590943,0.00009250517,0.0002755396,0.00007007604,0.00002549816],"category_scores_gemma":[0.0007361941,0.000119514,0.0000233039,0.00006620922,0.0003417891,0.0001714143,0.0001049501,0.0001580023,0.000001187043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001659452,"about_ca_system_score_gemma":0.0004690737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003192891,"about_ca_topic_score_gemma":0.002657724,"domain_scores_codex":[0.9983084,0.0003486672,0.0004270368,0.0003715248,0.0001814143,0.000362992],"domain_scores_gemma":[0.9979829,0.0005573786,0.0006103695,0.000540272,0.0002037094,0.0001054127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9856129,0.004259092,0.001151016,0.0001388955,0.0002075093,0.00007355506,0.0007678889,0.0000159372,0.0002834956,0.0001329327,0.0002805294,0.007076217],"study_design_scores_gemma":[0.9714425,0.01787494,0.006699134,0.0001277178,0.0006882797,0.0000118803,0.0001304208,0.001294295,0.0000474941,0.0001474097,0.00138377,0.0001521099],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794723,0.00009022466,0.00007549066,0.004416132,0.0002610318,0.01515,0.0001888417,0.00001884885,0.0003271833],"genre_scores_gemma":[0.9914568,0.00008402784,0.002709819,0.0003282668,0.0001697071,0.004761552,0.0001273174,0.00003121771,0.0003312957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01417039,"threshold_uncertainty_score":0.4873638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0888808162791997,"score_gpt":0.4204282111513942,"score_spread":0.3315473948721945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}